3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid

C115H114B2Br4N22O6Si2 — CID 160918466

IUPAC3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid
SMILESCC1(C)OB(c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3COCC[Si](C)(C)C)OC1(C)C.Cc1c(-c2cccnc2)cncc1-c1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1.Cc1c(-c2cccnc2)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C.Cc1c(Br)cncc1-c1cccnc1.Cc1c(Br)cncc1-c1cccnc1.Cc1c(Br)cncc1Br.OB(O)c1cccnc1
InChIInChI=1S/C31H32N6OSi.C26H35BN4O3Si.C25H18N6.2C11H9BrN2.C6H5Br2N.C5H6BNO2/c1-21-25(18-33-19-26(21)23-8-7-13-32-17-23)22-11-12-29-24(16-22)30(31-34-27-9-5-6-10-28(27)35-31)36-37(29)20-38-14-15-39(2,3)4;1-25(2)26(3,4)34-27(33-25)18-12-13-22-19(16-18)23(24-28-20-10-8-9-11-21(20)29-24)30-31(22)17-32-14-15-35(5,6)7;1-15-19(13-27-14-20(15)17-5-4-10-26-12-17)16-8-9-21-18(11-16)24(31-30-21)25-28-22-6-2-3-7-23(22)29-25;2*1-8-10(6-14-7-11(8)12)9-3-2-4-13-5-9;1-4-5(7)2-9-3-6(4)8;8-6(9)5-2-1-3-7-4-5/h5-13,16-19H,14-15,20H2,1-4H3,(H,34,35);8-13,16H,14-15,17H2,1-7H3,(H,28,29);2-14H,1H3,(H,28,29)(H,30,31);2*2-7H,1H3;2-3H,1H3;1-4,8-9H
InChIKeySRSHWJYLTLJQIO-UHFFFAOYSA-N
MW2297.74 g/mol
LogP26.16
Rot. Bonds21

About 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid

3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid (PubChem CID 160918466) has the molecular formula C115H114B2Br4N22O6Si2 and a molecular weight of 2297.74 g/mol. Its IUPAC name is 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid.

Molecular Properties

Compound Name3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid
PubChem CID160918466
Molecular FormulaC115H114B2Br4N22O6Si2
Molecular Weight2297.74 g/mol
Exact Mass2292.57
IUPAC Name3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid
SMILESCC1(C)OB(c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3COCC[Si](C)(C)C)OC1(C)C.Cc1c(-c2cccnc2)cncc1-c1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1.Cc1c(-c2cccnc2)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C.Cc1c(Br)cncc1-c1cccnc1.Cc1c(Br)cncc1-c1cccnc1.Cc1c(Br)cncc1Br.OB(O)c1cccnc1
InChIInChI=1S/C31H32N6OSi.C26H35BN4O3Si.C25H18N6.2C11H9BrN2.C6H5Br2N.C5H6BNO2/c1-21-25(18-33-19-26(21)23-8-7-13-32-17-23)22-11-12-29-24(16-22)30(31-34-27-9-5-6-10-28(27)35-31)36-37(29)20-38-14-15-39(2,3)4;1-25(2)26(3,4)34-27(33-25)18-12-13-22-19(16-18)23(24-28-20-10-8-9-11-21(20)29-24)30-31(22)17-32-14-15-35(5,6)7;1-15-19(13-27-14-20(15)17-5-4-10-26-12-17)16-8-9-21-18(11-16)24(31-30-21)25-28-22-6-2-3-7-23(22)29-25;2*1-8-10(6-14-7-11(8)12)9-3-2-4-13-5-9;1-4-5(7)2-9-3-6(4)8;8-6(9)5-2-1-3-7-4-5/h5-13,16-19H,14-15,20H2,1-4H3,(H,34,35);8-13,16H,14-15,17H2,1-7H3,(H,28,29);2-14H,1H3,(H,28,29)(H,30,31);2*2-7H,1H3;2-3H,1H3;1-4,8-9H
InChIKeySRSHWJYLTLJQIO-UHFFFAOYSA-N
XLogP26.16
TPSA356.64 Ų
H-Bond Donors6
H-Bond Acceptors24
Rotatable Bonds21
Heavy Atoms151
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002297.74
LogP ≤ 526.16
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-bromo-6-(trifluoromethyl)pyridine;2-[[4-bromo-3-[6-(trifluoromethyl)-2-pyridinyl]pyrazol-1-yl]methoxy]ethyl-trimethylsilane;ethane;2-ethoxyethyl(trimethyl)silane;2-[[4-(3-isocyanoimidazo[1,2-a]pyridin-6-yl)-3-[6-(trifluoromethyl)-2-pyridinyl]pyrazol-1-yl]methoxy]ethyl-trimethylsilane;3-isocyano-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydroimidazo[1,2-a]pyridine;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;trimethyl-[2-[[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]methoxy]ethyl]silane;trimethyl-[2-[[3-[6-(trifluoromethyl)-2-pyridinyl]pyrazol-1-yl]methoxy]ethyl]silane
CID 158613274
CID 157121234
CID 157121234
1-[2-[5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;1-[2-[5-[5-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;methane;1-[[5-[3-(7-piperazin-1-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]methyl]piperidin-4-ol;7-piperazin-1-yl-2-[5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridine;1-[2-[5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol
CID 157126711
3,20,24,27,28,33-Hexazaheptacyclo[21.5.2.12,5.110,14.118,22.04,9.026,29]tritriaconta-1(28),2,4(9),5,7,10,12,14(32),18(31),19,21,23,25,29-tetradecaene;3,20,27,28,30,33-hexazaheptacyclo[21.5.2.12,5.110,14.118,22.04,9.026,29]tritriaconta-1(28),2,4(9),5,7,10,12,14(32),18(31),19,21,23(30),24,26(29)-tetradecaene;19-methyl-3,16,19,20,27,28,32-heptazaheptacyclo[21.5.2.12,5.110,14.04,9.018,22.026,29]dotriaconta-1(28),2,4(9),5,7,10,12,14(31),18(22),20,23(30),24,26(29)-tridecaene;19-methyl-3,8,16,19,20,27,28,32-octazaheptacyclo[21.5.2.12,5.110,14.04,9.018,22.026,29]dotriaconta-1(28),2,4,6,8,10,12,14(31),18(22),20,23(30),24,26(29)-tridecaene
CID 157206457
5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methylpyridine-3-carboxamide;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-4-methylpyridine-3-carboxamide;bis(5-bromo-4-methylpyridine-3-carboxamide);3,5-dibromo-4-methylpyridine;isocyanato(trimethyl)silane
CID 157248836
[3-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]phenyl]methanol;[3-[5-[3-(1H-benzimidazol-2-yl)-1-[(4-methoxyphenyl)methyl]indazol-5-yl]-4-methyl-3-pyridinyl]phenyl]methanol;3-(1H-benzimidazol-2-yl)-1-[(4-methoxyphenyl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis([3-(5-bromo-4-methyl-3-pyridinyl)phenyl]methanol);3,5-dibromo-4-methylpyridine;[3-(hydroxymethyl)phenyl]boronic acid
CID 157282691
CID 157447361
CID 157447361
3-bromo-4-methylpyridine;5-bromo-3-[2-(4-methyl-3-pyridinyl)ethynyl]pyridin-2-amine;5-bromo-2-(4-methyl-3-pyridinyl)-1H-pyrrolo[2,3-b]pyridine;bis(5-(1-ethyl-3-pyridin-3-ylpyrazol-5-yl)-2-(4-methyl-3-pyridinyl)-1H-pyrrolo[2,3-b]pyridine);3-ethynyl-4-methylpyridine;2-(4-methyl-3-pyridinyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine;trimethyl-[2-(4-methyl-3-pyridinyl)ethynyl]silane
CID 157469509
3-(1H-benzimidazol-2-yl)-5-(4-ethyl-5-pyridin-4-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-ethyl-5-pyridin-4-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-ethyl-5-pyridin-4-ylpyridine);3,5-dibromo-4-ethylpyridine;3,5-dibromopyridine;pyridin-4-ylboronic acid
CID 157585836
1-[5-[3-(1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3,4-dihydro-2H-quinolin-1-yl]ethanone;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;1-[5-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilylethoxymethyl)indazol-5-yl]-3,4-dihydro-2H-quinolin-1-yl]ethanone;bis(1-(5-bromo-3,4-dihydro-2H-1,7-naphthyridin-1-yl)ethanone);2-[(5-bromo-3,4-dihydro-2H-1,7-naphthyridin-1-yl)sulfonyl]ethyl-trimethylsilane;5-bromo-1,2,3,4-tetrahydro-1,7-naphthyridine
CID 157605626
3-(1H-benzimidazol-2-yl)-1-methyl-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazole;3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;3-(1H-benzimidazol-2-yl)-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid
CID 157737998
3-(1H-benzimidazol-2-yl)-5-(4-chloro-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-chloro-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;4-chloro-3-iodopyridine;trimethyl-[2-[[3-(4-methyl-2,3-dihydro-1H-inden-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl]silane
CID 157893509

Frequently Asked Questions

What is the IUPAC name of 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid?
The IUPAC name of 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid (CID 160918466) is 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid.
What is the SMILES notation for 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid?
The canonical SMILES for 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid is CC1(C)OB(c2ccc3c(c2)c(-c2nc4ccccc4[nH]2)nn3COCC[Si](C)(C)C)OC1(C)C.Cc1c(-c2cccnc2)cncc1-c1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1.Cc1c(-c2cccnc2)cncc1-c1ccc2c(c1)c(-c1nc3ccccc3[nH]1)nn2COCC[Si](C)(C)C.Cc1c(Br)cncc1-c1cccnc1.Cc1c(Br)cncc1-c1cccnc1.Cc1c(Br)cncc1Br.OB(O)c1cccnc1.
What is the InChIKey of 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid?
The InChIKey is SRSHWJYLTLJQIO-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H32N6OSi.C26H35BN4O3Si.C25H18N6.2C11H9BrN2.C6H5Br2N.C5H6BNO2/c1-21-25(18-33-19-26(21)23-8-7-13-32-17-23)22-11-12-29-24(16-22)30(31-34-27-9-5-6-10-28(27)35-31)36-37(29)20-38-14-15-39(2,3)4;1-25(2)26(3,4)34-27(33-25)18-12-13-22-19(16-18)23(24-28-20-10-8-9-11-21(20)29-24)30-31(22)17-32-14-15-35(5,6)7;1-15-19(13-27-14-20(15)17-5-4-10-26-12-17)16-8-9-21-18(11-16)24(31-30-21)25-28-22-6-2-3-7-23(22)29-25;2*1-8-10(6-14-7-11(8)12)9-3-2-4-13-5-9;1-4-5(7)2-9-3-6(4)8;8-6(9)5-2-1-3-7-4-5/h5-13,16-19H,14-15,20H2,1-4H3,(H,34,35);8-13,16H,14-15,17H2,1-7H3,(H,28,29);2-14H,1H3,(H,28,29)(H,30,31);2*2-7H,1H3;2-3H,1H3;1-4,8-9H.
What are the key properties of 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid?
3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid has a molecular weight of 2297.74 g/mol, XLogP of 26.16, 21 rotatable bonds, 6 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)-1H-indazole;2-[[3-(1H-benzimidazol-2-yl)-5-(4-methyl-5-pyridin-3-yl-3-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;2-[[3-(1H-benzimidazol-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl-trimethylsilane;bis(3-bromo-4-methyl-5-pyridin-3-ylpyridine);3,5-dibromo-4-methylpyridine;pyridin-3-ylboronic acid is sourced from PubChem (CID 160918466), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).